---
figid: PMC2704523__opth-1-393f2
figlink: /pmc/articles/PMC2704523/figure/f2-co-1-393/
number: Figure 2
caption: 'VEGF receptor-induced signaling pathway. VEGF plays a key role in physiological
  blood vessel formation and pathological angiogenesis such as tumor growth and ischemic
  diseases. VEGF-dependent cell survival is mediated via phosphatidyl inositol-3-kinase
  (PI3K)-induced activation of the anti-apoptotic kinase Akt, which inhibits the protein
  Bad, leading to inhibition of caspase activity and also causes Ca2+-independent
  activation of nitric oxide synthetase (NOS) through phosphorylation. This pathway
  is necessary for cellular migration. A major mitogenic signaling mechanism for VEGF
  involves activation of phospholipase C (PLC-γ) resulting in hydrolysis of phosphatidylinositol
  4,5-bisphosphate, production of inositol 1,4,5-trisphosphate (IP3) and diacylglycerol
  (DAG), and subsequent mobilization of intracellular Ca2+ and protein kinase C (PKC)
  activation. PKC mediates activation of extracellular signal regulated kinases (ERK)
  1/2 via RAS, Raf-1 and MEK, mediating mitogenesis in association with mitogen-activated
  protein kinases (MAPK). Binding of the growth factor to its corresponding cell surface
  receptor (VEGFR) activates complex signal transduction pathways, involving changes
  in protein phosphorylation, ion fluxes, gene expression, protein synthesis and ultimately
  a biological response related with angiogenesis. Functional signaling converges
  at several points, emphasizing how signaling pathways are integrated to form signal
  transduction networks. For inhibition of this signaling pathway, the Pegaptanib
  binds to VEGF, blocking the formation of the complex VEGF-receptor and consequently
  inhibiting signal transduction and angiogenesis.Abbreviation: ER, endoplasmic reticulum.'
pmcid: PMC2704523
papertitle: Development of the anti-VEGF aptamer to a therapeutic agent for clinical
  ophthalmology.
reftext: Cleber A Trujillo, et al. Clin Ophthalmol. 2007 Dec;1(4):393-402.
pmc_ranked_result_index: '27377'
pathway_score: 0.9536182
filename: opth-1-393f2.jpg
figtitle: VEGF receptor-induced signaling pathway
year: '2007'
organisms: Homo sapiens
ndex: 62cb5c78-dedb-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2704523__opth-1-393f2.html
  '@type': Dataset
  description: 'VEGF receptor-induced signaling pathway. VEGF plays a key role in
    physiological blood vessel formation and pathological angiogenesis such as tumor
    growth and ischemic diseases. VEGF-dependent cell survival is mediated via phosphatidyl
    inositol-3-kinase (PI3K)-induced activation of the anti-apoptotic kinase Akt,
    which inhibits the protein Bad, leading to inhibition of caspase activity and
    also causes Ca2+-independent activation of nitric oxide synthetase (NOS) through
    phosphorylation. This pathway is necessary for cellular migration. A major mitogenic
    signaling mechanism for VEGF involves activation of phospholipase C (PLC-γ) resulting
    in hydrolysis of phosphatidylinositol 4,5-bisphosphate, production of inositol
    1,4,5-trisphosphate (IP3) and diacylglycerol (DAG), and subsequent mobilization
    of intracellular Ca2+ and protein kinase C (PKC) activation. PKC mediates activation
    of extracellular signal regulated kinases (ERK) 1/2 via RAS, Raf-1 and MEK, mediating
    mitogenesis in association with mitogen-activated protein kinases (MAPK). Binding
    of the growth factor to its corresponding cell surface receptor (VEGFR) activates
    complex signal transduction pathways, involving changes in protein phosphorylation,
    ion fluxes, gene expression, protein synthesis and ultimately a biological response
    related with angiogenesis. Functional signaling converges at several points, emphasizing
    how signaling pathways are integrated to form signal transduction networks. For
    inhibition of this signaling pathway, the Pegaptanib binds to VEGF, blocking the
    formation of the complex VEGF-receptor and consequently inhibiting signal transduction
    and angiogenesis.Abbreviation: ER, endoplasmic reticulum.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT2
  - VEGFB
  - PRKCD
  - MAPK11
  - PIK3R3
  - PRKCG
  - PRKCQ
  - VEGFC
  - PRKD3
  - PRKCA
  - PRKCE
  - MAPK3
  - PIK3CD
  - PIK3R6
  - PIK3R5
  - HRAS
  - KRAS
  - PRKCH
  - AKT3
  - PGF
  - VEGFA
  - PIK3CB
  - NOS3
  - PRKCZ
  - PRKCB
  - PIK3R4
  - MAPK14
  - NRAS
  - AKT1
  - PLCG2
  - MAPK10
  - PIK3CA
  - VEGFD
  - MAPK8
  - NOS2
  - MAPK1
  - MAPK9
  - PIK3CG
  - NOS1
  - MAPK13
  - PLCG1
  - PRKCI
  - MAPK12
  - Pegaptanib
  - Cancer
genes:
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: NOS
  symbol: NOS
  source: bioentities_symbol
  hgnc_symbol: NOS3
  entrez: '4846'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PLCY
  symbol: PLCG
  source: bioentities_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: NOS
  symbol: NOS
  source: bioentities_symbol
  hgnc_symbol: NOS2
  entrez: '4843'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: NOS
  symbol: NOS
  source: bioentities_symbol
  hgnc_symbol: NOS1
  entrez: '4842'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: PLCY
  symbol: PLCG
  source: bioentities_symbol
  hgnc_symbol: PLCG1
  entrez: '5335'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
chemicals:
- word: Pegaptanib
  source: MESH
  identifier: C495058
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
